Back
Bellevue Life Sciences Acquisition Quote, Financials, Valuation and Earnings
Hedge fund manager warns about the market ahead
Free book prepares you for the coming uncertainty in the stock market
Sell
32
BLAC
Bellevue Life Sciences Acquisition
Last Price:
10.91
Seasonality Move:
0.77%
7 Day Trial
ALL ACCESS PASS
$
7
32,481% Growth? Meet Mode Mobile's "EarnPhone"
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.Bellevue Life Sciences Acquisition Price Quote
$10.91
+0.02 (+0%)
(Updated: September 20, 2024 at 6:25 AM ET)
Bellevue Life Sciences Acquisition Key Stats
Sell
32
Bellevue Life Sciences Acquisition (BLAC)
is a Sell
Day range:
$10.89 - $10.89
52-week range:
$10.39 - $11.60
Dividend yield:
0%
P/E ratio:
217.80
P/S ratio:
0.00
P/B ratio:
2.91%
Volume:
0
Avg. volume:
8.3K
1-year change:
4.81%
Market cap:
$44M
Revenue:
$0
EPS:
$-0.03
How Much Does Bellevue Life Sciences Acquisition Make?
Data Unavailable
Is Bellevue Life Sciences Acquisition Growing As A Company?
Data Unavailable
Bellevue Life Sciences Acquisition Stock Price Performance
-
Did Bellevue Life Sciences Acquisition Stock Go Up Last Month?
Bellevue Life Sciences Acquisition share price went up by 0.74% last month -
Did BLAC's Share Price Rise Over The Last Year?
BLAC share price rose by 4.81% over the past 1 year
What Is Bellevue Life Sciences Acquisition 52-Week High & Low?
-
What Is Bellevue Life Sciences Acquisition’s 52-Week High Share Price?
Bellevue Life Sciences Acquisition has traded as high as $11.60 over the past 52 weeks -
What Is Bellevue Life Sciences Acquisition’s 52-Week Low Share Price?
Bellevue Life Sciences Acquisition has traded as low as $10.39 over the past 52 weeks
Bellevue Life Sciences Acquisition Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Bellevue Life Sciences Acquisition?
-
How Much Debt Does Bellevue Life Sciences Acquisition Have?
Total long term debt quarterly is $0 -
How Much Cash Does Bellevue Life Sciences Acquisition Have?
Cash and short term investments quarterly total is $119.1K -
What Is Bellevue Life Sciences Acquisition’s Book Value Per Share?
Book value per share is 3.75
Is Bellevue Life Sciences Acquisition Cash Flow Positive?
-
What Is BLAC Cash Flow From Operations?
Cash flow from operations (TTM) is -$1.9M -
What Is Bellevue Life Sciences Acquisition’s Cash Flow From Financing?
Cash flow from financing (TTM) is -$51.5M -
What Is Bellevue Life Sciences Acquisition’s Cash Flow From Investing?
Cash flow from investing (TTM) is $53.5M
Bellevue Life Sciences Acquisition Return On Invested Capital
Data Unavailable
Bellevue Life Sciences Acquisition Earnings Date & Stock Price
-
What Is Bellevue Life Sciences Acquisition's Stock Price Today?
A single share of BLAC can be purchased today for 10.89 -
What Is Bellevue Life Sciences Acquisition’s Stock Symbol?
Bellevue Life Sciences Acquisition trades on the nasdaq under the ticker symbol: BLAC -
When Is Bellevue Life Sciences Acquisition’s Next Earnings Date?
The next quarterly earnings date for Bellevue Life Sciences Acquisition is scheduled on November 7, 2024 -
When Is BLAC's next ex-dividend date?
Bellevue Life Sciences Acquisition's next ex-dividend date is September 20, 2024 -
How To Buy Bellevue Life Sciences Acquisition Stock?
You can buy Bellevue Life Sciences Acquisition shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Bellevue Life Sciences Acquisition Competitors
-
Who Are Bellevue Life Sciences Acquisition's Competitors?
Below is a list of companies who compete with Bellevue Life Sciences Acquisition or are related in some way:
Bellevue Life Sciences Acquisition Dividend Yield
-
What Is BLAC Dividend Yield?
Bellevue Life Sciences Acquisition’s dividend yield currently is 0% -
What Is Bellevue Life Sciences Acquisition’s Payout Ratio?
Bellevue Life Sciences Acquisition’s payout ratio is 0% -
When Did Bellevue Life Sciences Acquisition Last Pay A Dividend?
The latest dividend pay date is September 20, 2024 -
What Is Bellevue Life Sciences Acquisition’s Dividend Per Share?
Bellevue Life Sciences Acquisition pays a dividend of $0.00 per share
Bellevue Life Sciences Acquisition Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 0% |
| Revenue: | 0% | 0% |
Analyst Recommendations
| Buy Recommendations: | 0 |
|---|---|
| Hold Recommendations: | 0 |
| Sell Recommendations: | 0 |
| Price Target: | 0.00 |
| Downside from Last Price: | -100% |